Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-074408
Filing Date
2014-02-28
Accepted
2014-02-28 06:09:34
Documents
13
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d684049d6k.htm 6-K 355407
2 GRAPHIC g684049tx_logo.jpg GRAPHIC 7398
3 GRAPHIC g684049tx_pg003.jpg GRAPHIC 12469
4 GRAPHIC g684049tx_pg004.jpg GRAPHIC 4176
5 GRAPHIC g684049tx_pg006.jpg GRAPHIC 4240
6 GRAPHIC g684049tx_pg010.jpg GRAPHIC 4158
7 GRAPHIC g684049tx_pg011a.jpg GRAPHIC 9356
8 GRAPHIC g684049tx_pg011b.jpg GRAPHIC 4753
9 GRAPHIC g684049tx_pg011c.jpg GRAPHIC 3710
10 GRAPHIC g684049tx_pg026.jpg GRAPHIC 4221
11 GRAPHIC g684049tx_pg028a.jpg GRAPHIC 5087
12 GRAPHIC g684049tx_pg028b.jpg GRAPHIC 4992
13 GRAPHIC g684049tx_pg028c.jpg GRAPHIC 3695
  Complete submission text file 0001193125-14-074408.txt   452293
Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077
Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 14651331
SIC: 2834 Pharmaceutical Preparations